Advertisement

Topics

"Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" Drugs and Medication Database

05:16 EST 21st February 2019 | BioPortfolio

Here are the most relevant "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" Drugs and Medications that we have found in our database.

More Information about "Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL)" on BioPortfolio

We have published hundreds of Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) news stories on BioPortfolio along with dozens of Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) Clinical Trials and PubMed Articles about Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) Companies in our database. You can also find out about relevant Study of BuEAM Conditioning for Autologous Stem Cell Transplantation (ASCT) to Treat Diffuse Large B Cell Lymphoma (DLCBL) Drugs and Medications on this site too.

Showing "Study BuEAM Conditioning Autologous Stem Cell Transplantation ASCT" Drugs and Medications 1–25 of 102

Probably Relevant

Evomela [spectrum pharmaceuticals, inc.]

These highlights do not include all the information needed to use EVOMELA safely and effectively. See full prescribing information for EVOMELA. EVOMELA (melphalan) for injection, for intravenous use.Initial U.S. Approval: 1964

Cpd [fenwal, inc.]

Anticoagulant citrate dextrose a [citra labs]

ACD-A Anticoagulant Citrate Dextrose Solution, Solution A, U.S.P., PN 9350, 30 mL NDC 23731-6051-3

Kepivance [swedish orphan biovitrum ab (publ)]

These highlights do not include all the information needed to use Kepivance safely and effectively. See full prescribing information for KEPIVANCE. KEPIVANCE (palifermin) for injection, for intravenous use Initial U.S. Approval: 2004

Indium 111 oxyquinolone [anazaohealth corporation]

Indium 111 Oxyquinolone (In-111 Oxine)

Revlimid [celgene corporation]

These highlights do not include all the information needed to use REVLIMID safely and effectively. See full prescribing information for REVLIMID. REVLIMID [lenalidomide] capsules, for oral use Initial U.S. Approval: 2005

Possibly Relevant

Myleran [aspen global inc.]

MYLERAN (busulfan)Tablets

Busulfex [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use BUSULFEX safely and effectively. See full prescribing information for BUSULFEX. BUSULFEX (busulfan) Injection, for intravenous use Initial U.S. Approval: 1999

Busulfan [amneal biosciences llc]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION. BUSULFAN injection, for intravenous use Initial U.S. Approval: 1999

Busulfex [otsuka america pharmaceutical, inc.]

These highlights do not include all the information needed to use BUSULFEX safely and effectively. See full prescribing information for BUSULFEX. BUSULFEX (busulfan) Injection, for intravenous use Initial U.S. Approval: 1999

Busulfan [actavis pharma, inc.]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION.   BUSULFAN injection, for intravenous use Initial U.S. Approval: 1999

Busulfan [mylan institutional llc]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION.   BUSULFAN injection, for intravenous infusion use Initial U.S. Approval: 1999

Adcetris [seattle genetics, inc.]

These highlights do not include all the information needed to use ADCETRIS safely and effectively.  See full prescribing information for ADCETRIS. ADCETRIS (brentuximab vedotin) for injection, for intravenous useInitial U.S. approval: 2011

Leukine [partner therapeutics, inc]

These highlights do not include all the information needed to use LEUKINE safely and effectively. See full prescribing information for LEUKINE. LEUKINE (sargramostim) for injection, for subcutaneous or intravenous useLEUKINE (sargramostim) injection, for

Leukine [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use LEUKINE safely and effectively. See full prescribing information for LEUKINE. LEUKINE (sargramostim) for injection, for subcutaneous or intravenous useLEUKINE (sargramostim) injection, for

Busulfan [sagent pharmaceuticals]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION. BUSULFAN injection, for intravenous infusionInitial U.S. Approval: 1999

Busulfan [pharmascience inc.]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION. BUSULFAN injection, for intravenous use Initial U.S. Approval: 1999

N/a [american regent, inc.]

These highlights do not include all the information needed to use BUSULFAN INJECTION safely and effectively. See full prescribing information for BUSULFAN INJECTION. BUSULFAN INJECTION, for intravenous useInitial U.S. Approval: 1999

Mozobil [sanofi-aventis u.s. llc]

These highlights do not include all the information needed to use MOZOBIL safely and effectively. See full prescribing information for MOZOBIL. MOZOBIL (plerixafor) Injection, Solution for subcutaneous use Initial U.S. Approval: 2008

Indium in 111 oxyquinoline [medi-physics inc. dba ge healthcare.]

INDIUM IN 111OXYQUINOLINE SOLUTION

Unituxin [united therapeutics corp.]

These highlights do not include all the information needed to use UNITUXIN safely and effectively. See Full Prescribing Information for UNITUXIN. UNITUXIN (dinutuximab) injection, for intravenous use Initial U.S. Approval: 2015

Carticel [vericel corporation]

These highlights do not include all the information needed to use Carticel safely and effectively. See full prescribing information for Carticel. Carticel (autologous cultured chondrocytes) For Autologous Implantation Initial U.S. Approval: 1997

Zarxio [sandoz inc]

These highlights do not include all the information needed to use ZARXIO safely and effectively. See full prescribing information for ZARXIO.ZARXIO (filgrastim-sndz) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2015

Zarxio [sandoz inc.]

These highlights do not include all the information needed to use ZARXIO safely and effectively. See full prescribing information for ZARXIO.ZARXIO (filgrastim-sndz) injection, for subcutaneous or intravenous useInitial U.S. Approval: 2015

Sirolimus [american health packaging]

These highlights do not include all the information needed to use SIROLIMUS TABLETS safely and effectively. See full prescribing information for SIROLIMUS TABLETS. SIROLIMUS tablets, for oral use Initial U.S. Approval: 1999



Advertisement
Quick Search
Advertisement
Advertisement